As well as translating research to make it easier to understand, MStranslate is committed to making research updates more accessible to the public. This involves not only summarising published journal articles, but also providing insights into conferences that are often restricted to researchers and the medical community.

The ECTRIMS Congress in 2015 was one of the largest MS conferences ever held. We have interviewed three neurologists from the Royal Melbourne Hospital who attended the conference and asked them to answer some important questions regarding the discussions that took place. In Part 1, we asked them to talk about the key themes of the 2015 conference and how it differed to the 2014 ECTRIMS meeting.

In the second part of our video series on ECTRIMS Congress 2015, we asked our three neurologists from the Royal Melbourne Hospital to discuss their highlights from the conference. They provided details on presentations covering topics such as long-term outcomes of treatment trials, the factors that impact on multiple sclerosis progression and developments in the field of progressive MS.

In the third and final part of our video series on ECTRIMS Congress 2015, we asked our three neurologists from the Royal Melbourne Hospital to answer the following questions:

1) If you had a crystal ball, what would you predict will be the biggest advances in multiple sclerosis research over the next 12 months, that will be discussed at ECTRIMS 2016?

2) What research developments will provide the most benefits for people with MS over the next 5 years?

We thank Dr Anneke Van der Walt, Dr Tomas Kalincik and Professor John King for volunteering their time to film these videos, their support is greatly appreciated.

The 32nd ECTRIMS Congress will take place in London, England, between the 14th and 17th of September, 2016.  It will be run in parallel with the 21st Annual Conference of Rehabilitation in MS.  We look forward to bringing you coverage of these two events as they occur.

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.